GSK-109493

Study Sponsor: GSK

Study Title

GSK1572932A Antigen-Specific Cancer Immunotherapeutic as adjuvant therapy in patients with resectable MAGE-A3 positive Non-Small Cell Lung Cancer

Medicine or Vaccine (generic name)

GSK1572932A

Sponsor Identification Number

109493

Trial Registry Identification Number(#'s)

NCT00480025 2007-001283-73

Medical Condition

Lung Cancer, Non-Small Cell

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

May 2017